RA Capital Management - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 112 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,547,086
+34.5%
11,609,7040.0%1.02%
+40.4%
Q2 2023$38,312,023
+15.8%
11,609,7040.0%0.72%
-3.5%
Q1 2023$33,087,656
-52.2%
11,609,704
+22.1%
0.75%
-46.7%
Q4 2022$69,203,134
+22.2%
9,505,925
+35.8%
1.40%
+16.2%
Q3 2022$56,630,0007,000,0001.21%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders